These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

310 related items for PubMed ID: 18838096

  • 1. Genetic characterization and protective immunity of cold-adapted attenuated avian H9N2 influenza vaccine.
    Lee JS, Kim HS, Seo SH.
    Vaccine; 2008 Dec 02; 26(51):6569-76. PubMed ID: 18838096
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Generation and protective efficacy of a cold-adapted attenuated avian H9N2 influenza vaccine.
    Wei Y, Qi L, Gao H, Sun H, Pu J, Sun Y, Liu J.
    Sci Rep; 2016 Jul 26; 6():30382. PubMed ID: 27457755
    [Abstract] [Full Text] [Related]

  • 6. H9N2 influenza viruses isolated from poultry in Korean live bird markets continuously evolve and cause the severe clinical signs in layers.
    Kim JA, Cho SH, Kim HS, Seo SH.
    Vet Microbiol; 2006 Dec 20; 118(3-4):169-76. PubMed ID: 16930870
    [Abstract] [Full Text] [Related]

  • 7. Comparative efficacy of North American and antigenically matched reverse genetics derived H5N9 DIVA marker vaccines against highly pathogenic Asian H5N1 avian influenza viruses in chickens.
    Jadhao SJ, Lee CW, Sylte M, Suarez DL.
    Vaccine; 2009 Oct 19; 27(44):6247-60. PubMed ID: 19686695
    [Abstract] [Full Text] [Related]

  • 8. Generation and evaluation of an H9N1 influenza vaccine derived by reverse genetics that allows utilization of a DIVA strategy for control of H9N2 avian influenza.
    Wu R, Chen Q, Zheng L, Chen J, Sui Z, Guan Y, Chen Z.
    Arch Virol; 2009 Oct 19; 154(8):1203-10. PubMed ID: 19543688
    [Abstract] [Full Text] [Related]

  • 9. Generation and evaluation of the trivalent inactivated reassortant vaccine using human, avian, and swine influenza A viruses.
    Du N, Li W, Li Y, Liu S, Sui Y, Qu Z, Wang Y, Du Y, Xu B.
    Vaccine; 2008 Jun 02; 26(23):2912-8. PubMed ID: 18448208
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. A live bivalent influenza vaccine based on a H9N2 virus strain.
    Wu R, Guan Y, Yang Z, Chen J, Wang H, Chen Q, Sui Z, Fang F, Chen Z.
    Vaccine; 2010 Jan 08; 28(3):673-80. PubMed ID: 19892041
    [Abstract] [Full Text] [Related]

  • 15. Genetic mapping of the cold-adapted phenotype of B/Ann Arbor/1/66, the master donor virus for live attenuated influenza vaccines (FluMist).
    Chen Z, Aspelund A, Kemble G, Jin H.
    Virology; 2006 Feb 20; 345(2):416-23. PubMed ID: 16289204
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Genetic analysis of H9N2 avian influenza viruses isolated from India.
    Tosh C, Nagarajan S, Behera P, Rajukumar K, Purohit K, Kamal RP, Murugkar HV, Gounalan S, Pattnaik B, Vanamayya PR, Pradhan HK, Dubey SC.
    Arch Virol; 2008 Feb 20; 153(8):1433-9. PubMed ID: 18568381
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.